It is strictly prohibited to administer these products to humans or animals under any circumstances
They warn that the lack of rigorous clinical trials and standardized protocols raise serious safety concerns, including the risk of hepatotoxicity (liver damage caused by chemicals) and allergic reactions like anaphylaxis
GLP-3 R is a supplier shorthand for the triple-receptor agonist peptide identified by CAS 2381089-83-2 (also known as retatrutide / LY3437943), formula C221H342N46O68
Nhn chung, bn ch cn tun th s dng sn phm mi ngy theo liu trnh quy nh, kt hp cng n ung ngh ngi khoa hc, trnh xa cc cht kch thch, luyn tp th thao thng xuyn,
Uh, and I think probably the first clinical indications are gonna be for patients with chronic conditions if it, if it pans out for like irrit, irritable bowel syndrome, Crohn's, uh, Marissa Liza: and that was sort of the non-athlete, the total healthcare provider part of me that was really interested in this